Inactive Instrument

IRRAS AB Stock OTC Markets

Equities

IRRA.F

SE0008321202

Medical Equipment, Supplies & Distribution

Financials

Sales 2023 * 165M 15.55M 21.36M Sales 2024 * 249M 23.42M 32.18M Capitalization 182M 17.13M 23.53M
Net income 2023 * -101M -9.52M -13.08M Net income 2024 * -29M -2.73M -3.75M EV / Sales 2023 * 2.38 x
Net Debt 2023 * 211M 19.86M 27.28M Net Debt 2024 * 258M 24.3M 33.38M EV / Sales 2024 * 1.77 x
P/E ratio 2023 *
-0.13 x
P/E ratio 2024 *
-0.43 x
Employees 47
Yield 2023 *
-
Yield 2024 *
-
Free-Float 3.55%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 49 17-12-31
Director of Finance/CFO 38 -
Director/Board Member 66 15-05-31
Members of the board TitleAgeSince
Chairman 51 11-12-31
Director/Board Member 66 15-05-31
Director/Board Member 69 17-08-31
More insiders
Irras AB is a Sweden-based medical technology company. It offers devices for fluid control and management for a broad range of brain pathologies, central nervous system (CNS) therapeutic applications and procedures. The offer comprises instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow. The IRRAflow CNS System combines an External Drainage System, an intracranial pressure monitoring (ICP) Monitor and an Occlusion Solution Mechanism into a single, integrated device. The primary market for IRRAflow is the United States. The Company’s shareholders comprise Vandel Medical Equipment (CY) Limited, Serendipity Ixora AB (publ) and F.EX Endotherapy Limited, among others.
More about the company